c12-14 sec-pareth-15 hamilelikte güvenli mi?
The Cosmetic Ingredient Review (CIR) review of the Alkyl PEG/ethers (which explicitly includes C12–14 sec‑pareth variants such as C12‑14 sec‑pareth‑15) concluded these ingredients are "safe as used" and noted that reproductive/developmental toxicity is considered unlikely based on chemical and structural characteristics; there is no harmonised ECHA reproductive hazard classification (H360/H361) for this CAS, and no peer‑reviewed studies demonstrating reproductive toxicity specific to C12‑14 sec‑pareth‑15 were identified. (CIR; ECHA substance record; PubChem).
Related ingredients
Frequently asked questions
- c12-14 sec-pareth-15 hamilelikte güvenli mi?
- The Cosmetic Ingredient Review (CIR) review of the Alkyl PEG/ethers (which explicitly includes C12–14 sec‑pareth variants such as C12‑14 sec‑pareth‑15) concluded these ingredients are "safe as used" and noted that reproductive/developmental toxicity is considered unlikely based on chemical and structural characteristics; there is no harmonised ECHA reproductive hazard classification (H360/H361) for this CAS, and no peer‑reviewed studies demonstrating reproductive toxicity specific to C12‑14 sec‑pareth‑15 were identified. (CIR; ECHA substance record; PubChem).
- c12-14 sec-pareth-15 emzirirken güvenli mi?
- No evidence was found that C12–14 sec‑pareth‑15 causes reproductive or developmental effects, and CIR judged repro/developmental toxicity unlikely; there are no data indicating mechanisms or human effects that would contraindicate use during lactation. Typical use as a cosmetic surfactant with limited systemic bioavailability supports a 0 score absent contrary data. (CIR; PubChem).
- c12-14 sec-pareth-15 bebek cildi için güvenli mi?
- Hazard and mechanism: no infant‑specific reproductive or developmental hazards were identified (CIR). Exposure: because ethoxylated surfactants are moderately absorbed only under certain conditions and infant skin has higher absorption potential, the exposure score is increased by +1 for baby skin (0→1) despite no specific evidence of harm in infants; note CIR cautions about formulation to avoid irritation. If formulated to be non‑irritating the CIR concluded these are safe for topical use. (CIR; CIR ingredient page).
- VeriMom c12-14 sec-pareth-15 nasıl puanlıyor?
- VeriMom c12-14 sec-pareth-15'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte c12-14 sec-pareth-15 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.